- Reference code :
- wf523
- Published date :
-
23 October 2003
- Expired date :
-
10 March 2031
“Strong quarter contributes to a 2 percent increase in nine months sales; Key growth products up 56 percent; Full year earnings expected at or just above top of forecast range."
Download PDF files:
Narrative - 122 kb
Figures - 75 kb
Media Enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Chris Major, Tel: +44 (0) 207 304 5028
Narrative - 122 kb
Figures - 75 kb
Further enquiries to:
Media Enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Chris Major, Tel: +44 (0) 207 304 5028
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At Nov 21, 2009 10:43 AM GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
